Heidelberg Pharma Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
35
- Stock Symbol
-
HPHA
- Investments
-
2
- Share Price
-
$2.27
- (As of Thursday Closing)
Heidelberg Pharma General Information
Description
Heidelberg Pharma AG is a biopharmaceutical company developing oncology treatments through antibody drug conjugates (ADCs), which combine antibody specificity with toxin potency to selectively target and kill cancer cells. The Company researches, develops, and produces these ADCs, and has built an ADC toolbox using various antibodies and payloads to address multiple cancers and overcome tumor resistance. Its activities focus on its proprietary ATAC technology based on Amanitin, the toxin of the death cap mushroom, leveraging its biological mechanism as a novel cancer therapy. The ATAC platform is used to develop proprietary ADC candidates and is also applied in collaborations with third parties.
Contact Information
Website
www.heidelberg-pharma.comCorporate Office
- Gregor-Mendel-Stresse 22
- 68526 Ladenburg
- Germany
Corporate Office
- Gregor-Mendel-Stresse 22
- 68526 Ladenburg
- Germany
Heidelberg Pharma Stock Performance
As of 19-Nov-2026, Heidelberg Pharma’s stock price is $2.27. Its current market cap is $106M with 46.8M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.27 | $2.26 | $2.20 - $3.89 | $106M | 46.8M | 3.85K | -$0.76 |
Heidelberg Pharma Financials Summary
As of 31-Aug-2026, Heidelberg Pharma has a trailing 12-month revenue of $10.8M.
|
In Thousands, USD |
TTM 31-Aug-2026 | FY 2025 30-Nov-2025 | FY 2024 30-Nov-2024 | FY 2023 30-Nov-2023 |
|---|---|---|---|---|
| EV | 106,703 | 131,538 | 79,675 | 91,842 |
| Revenue | 10,843 | 1,628 | 7,438 | 10,640 |
| EBITDA | (30,703) | (43,888) | (21,495) | (21,941) |
| Net Income | (34,796) | (47,239) | (21,047) | (21,958) |
| Total Assets | 49,621 | 44,227 | 64,236 | 77,185 |
| Total Debt | 346 | 133 | 174 | 6,398 |
Heidelberg Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Heidelberg Pharma Comparisons
Industry
Financing
Details
Heidelberg Pharma Competitors (2)
One of Heidelberg Pharma’s 2 competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| Affimed | Formerly VC-backed | Mannheim, Germany |
Heidelberg Pharma Patents
Heidelberg Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014220705-A1 | Caix stratification based cancer treatment | Active | 22-Feb-2013 | ||
| AU-2014220705-B2 | Caix stratification based cancer treatment | Active | 22-Feb-2013 | ||
| AU-2014220705-C1 | Caix stratification based cancer treatment | Active | 22-Feb-2013 | ||
| CA-2901531-A1 | Caix stratification based cancer treatment | Active | 22-Feb-2013 | ||
| CA-2901531-C | Caix stratification based cancer treatment | Active | 22-Feb-2013 | G01N33/57525 |
Heidelberg Pharma Signals
Heidelberg Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Heidelberg Pharma Acquisitions (2)
Heidelberg Pharma’s most recent deal was a Merger/Acquisition with Heidelberg Pharma (Acquired by Wilex) for . The deal was made on 15-Dec-2010.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Heidelberg Pharma (Acquired by Wilex) | 15-Dec-2010 | Merger/Acquisition | Pharmaceuticals | ||
| Siemens Healthcare Diagnostics (Oncogene Science Business) | 18-Nov-2010 | Merger/Acquisition | Pharmaceuticals |
Heidelberg Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Heidelberg Pharma FAQs
-
When was Heidelberg Pharma founded?
Heidelberg Pharma was founded in 1997.
-
Where is Heidelberg Pharma headquartered?
Heidelberg Pharma is headquartered in Ladenburg, Germany.
-
What is the size of Heidelberg Pharma?
Heidelberg Pharma has 35 total employees.
-
What industry is Heidelberg Pharma in?
Heidelberg Pharma’s primary industry is Pharmaceuticals.
-
Is Heidelberg Pharma a private or public company?
Heidelberg Pharma is a Public company.
-
What is Heidelberg Pharma’s stock symbol?
The ticker symbol for Heidelberg Pharma is HPHA.
-
What is the current stock price of Heidelberg Pharma?
As of 19-Nov-2026 the stock price of Heidelberg Pharma is $2.27.
-
What is the current market cap of Heidelberg Pharma?
The current market capitalization of Heidelberg Pharma is $106M.
-
What is Heidelberg Pharma’s current revenue?
The trailing twelve month revenue for Heidelberg Pharma is $10.8M.
-
Who are Heidelberg Pharma’s competitors?
Genetix Biotherapeutics and Affimed are competitors of Heidelberg Pharma.
-
What is Heidelberg Pharma’s annual earnings per share (EPS)?
Heidelberg Pharma’s EPS for 12 months was -$0.76.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process